NCT06407271

Brief Summary

The aims of our study are to investigate in patients with immediate implantation replacing a single tooth in the maxillary anterior (#FDI 15-25) region the effect of (a) custom vs cylindrical stock healing abutments, then (b) screw retained single ceramic crowns, on the peri implant hard- and soft-tissue formation and blood flow.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
32mo left

Started Dec 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress48%
Dec 2023Dec 2028

Study Start

First participant enrolled

December 13, 2023

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 12, 2024

Completed
27 days until next milestone

First Posted

Study publicly available on registry

May 9, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2028

Expected
Last Updated

May 9, 2024

Status Verified

December 1, 2023

Enrollment Period

2 years

First QC Date

April 12, 2024

Last Update Submit

May 6, 2024

Conditions

Keywords

Peri-Implant Tissue ManagementCAD-CAMDental Implants, Single-ToothDental Implant-Abutment Design

Outcome Measures

Primary Outcomes (3)

  • midfacial keratinized mucosa volume

    Volume changes in midfacial mucosa \[mm\]

    4, 12, 36 months post op.

  • midfacial keratinized mucosa width

    Keratinized mucosa width \[mm\]

    4, 12, 36 months post op.

  • Keratinized mucosa thickness

    Keratinized mucosa thickness with ultrasound \[mm\]

    before implantation, 4,12, 36 months post op.

Secondary Outcomes (10)

  • soft tissue volume

    4, 12, 36 months post op.

  • laser speckle contrast imaging (LSCI)

    at 0-7., 0., 1., 4., 7., 14. day, and 1., 2., 4., 6., 12 month after implantation

  • ultrasound

    at 0-7., 0., 1., 4., 7., 14. day, and 1., 2., 4., 6., 12 month after implantation

  • marginal bone loss

    4, 12, 36 months post op.

  • Implant survival

    4, 12, 36 months

  • +5 more secondary outcomes

Study Arms (2)

CAD/CAM custom ZrO2 healing abutment

EXPERIMENTAL

Application of custom, zirconium-dioxide healing abutment, fabricated with computer aided design and manufacturing, following immediate implantation.

Device: CAD/CAM custom ZrO2 healing abutment

Cylindrical ZrO2 healing abutment

ACTIVE COMPARATOR

Application of cylindrical, zirconium-dioxide healing abutment following immediate implantation.

Device: Cylindrical ZrO2 healing abutment

Interventions

Application of custom, zirconium-dioxide healing abutment, fabricated with computer aided design and manufacturing, following immediate implantation.

Also known as: CAD-CAM custom zirconium-dioxide healing abutment
CAD/CAM custom ZrO2 healing abutment

Application of cylindrical, zirconium-dioxide healing abutment following immediate implantation.

Also known as: Cylindrical zirconium-dioxide healing abutment
Cylindrical ZrO2 healing abutment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients over 18 years
  • good general health
  • good oral hygiene (FMPS \< 25%)
  • healthy periodontium (PPD \< 4mm)
  • thick phenotype
  • maxilla anterior region (extended to 15-25 positions)
  • solo missing teeth, intact adjacent teeth
  • type 1 alveolar shape after extraction 1
  • retained occlusion
  • baseline buccal bone wall thickness at least 1.5 mm, based on intact CBCT scan
  • patient voluntarily accepts and signs the information and consent form for the study

You may not qualify if:

  • general ill health
  • general surgical or oral surgery contraindication
  • a patient who has undergone local radiotherapy
  • active periodontal inflammation, inflammation of the alveolar cavity
  • smoking
  • posterior region
  • pregnancy, lactation
  • psychological or mental involvement affecting individual plaque control
  • presence of an implant adjacent to the planned implant
  • inadequate oral hygiene
  • need for vertical bone augmentation
  • gingival recession
  • Inappropriate implant position for screw fixation
  • bruxism

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Semmelweis University, Department of Prosthodontics

Budapest, Pest County, 1088, Hungary

RECRUITING

Study Officials

  • Krisztina Mikulás, PhD

    Semmelweis University, Department of Prosthodontics

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Krisztina Mikulás, PhD

CONTACT

Péter Tajti

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 12, 2024

First Posted

May 9, 2024

Study Start

December 13, 2023

Primary Completion

December 30, 2025

Study Completion (Estimated)

December 30, 2028

Last Updated

May 9, 2024

Record last verified: 2023-12

Locations